 12 PM / Updated 10 minutes ago BRIEF-Achaogen Announces FDA Acceptance Of New Drug Application With Priority Review For Plazomicin Reuters Staff 1 Min Read 
Jan 2 (Reuters) - Achaogen Inc: 
* ACHAOGEN ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION WITH PRIORITY REVIEW FOR PLAZOMICIN FOR TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND BLOODSTREAM INFECTIONS 
* ACHAOGEN - INTENDS TO SUBMIT APPLICATION FOR MARKETING AUTHORIZATION FOR PLAZOMICIN IN EUROPEAN UNION IN 2018 Source text for Eikon: Further company coverage: